Bliss GVS Pharma Ltd 2025 Annual Report with Sustainability Disclosures
Company: Bliss GVS Pharma Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 237
The report presents FY2024-25 consolidated revenue of INR 80,972.62 Lakh and highlights the commissioning of an additional 3 MW solar capacity in Q4 FY2025. It also reports three women among six directors, equal to 50% representation on the board. The BRSR provides detailed sustainability disclosures, but explicitly states that its reporting boundary is standalone.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.